IGC
IGC
AMEX · Pharmaceuticals

Igc Pharma Inc

$0.29
+0.02 (+6.98%)
As of Sep 20, 10:59 PM ET ·
Financial Highlights (FY 2026)
Revenue
966.9K
Net Income
-4,607,807
Gross Margin
34.2%
Profit Margin
-477.1%
Rev Growth
-1.5%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 34.2% 34.2% 57.7% 57.7%
Operating Margin -891.2% -802.1% 15.4% 17.4%
Profit Margin -477.1% -453.3% 15.5% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 966.9K 981.9K 13.95M 13.36M
Gross Profit 330.5K 335.6K 8.05M 7.71M
Operating Income -8,617,924 -7,875,844 2.14M 2.33M
Net Income -4,607,807 -4,211,034 2.16M 1.76M
Gross Margin 34.2% 34.2% 57.7% 57.7%
Operating Margin -891.2% -802.1% 15.4% 17.4%
Profit Margin -477.1% -453.3% 15.5% 13.2%
Rev Growth -1.5% -1.5% +17.1% -6.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 250.0K 250.0K 9.96M 10.38M
Total Equity 13.81M 13.81M 19.20M 17.06M
D/E Ratio 0.02 0.02 0.52 0.61
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -8,238,798 -7,947,662 3.52M 3.64M
Free Cash Flow 2.06M 1.63M